Trial Profile
A multi-center, double-blind, placebo-controlled study of bupropion XL in females with orgasmic disorder
Status:
Completed
Phase of Trial:
Phase II/III
Latest Information Update: 20 Aug 2023
Price :
$35
*
At a glance
- Drugs Bupropion (Primary)
- Indications Female sexual dysfunction
- Focus Therapeutic Use
- 19 Jul 2011 Actual end date (Apr 2007) added as reported by ClinicalTrials.gov.
- 19 Jul 2011 Status changed from recruiting to completed as reported by ClinicalTrials.gov.
- 28 Oct 2006 New trial record.